Clinical Trial Update: Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on a tacrolimus once-daily immunosuppressive regimen shows a slow and low start; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Disease
• Renal Failure
• Renal Insufficiency

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Renal Failure, Renal Insufficiency | Phase 3 | Status: UNKNOWN